Devsynthesis

Executive Summary

Devsynthesis is a fast-growing Discovery Chemistry CRO headquartered in Barcelona, Spain, with primary operations in India. Founded in 2014, the company specializes in custom synthesis, analytical services, and discovery chemistry support for biotech, pharmaceutical, and academic clients. Its core offering focuses on delivering rare and complex molecules through cost-effective, high-quality services on both project-based and full-time equivalent engagement models. The company's dual presence in Europe and India positions it well to serve a global client base, leveraging cost advantages without compromising quality. As a private entity, Devsynthesis operates in the competitive CRO landscape, but its niche in complex molecule synthesis and flexible engagement models may drive steady growth. The company has not raised institutional capital publicly, suggesting self-sustaining operations or early-stage status. Its profile remains limited, with no disclosed employee range, stage, or financials, but its listing on BiopharmGuy and active website indicate ongoing business development.

Upcoming Catalysts (preview)

• Q3 2026Expansion of Indian Operations or New Laboratory Capacity70% success
• TBDStrategic Partnership or Collaboration with a Major Pharma/Biotech50% success
• TBDAward of a Significant Multi-Year FTE Contract60% success